Hospira Epirubicin Hydrochloride Injection 10 mg/5 mL single dose vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
27-11-2017

유효 성분:

epirubicin hydrochloride, Quantity: 2 mg/mL

제공처:

Hospira Australia Pty Ltd

INN (국제 이름):

epirubicin hydrochloride

약제 형태:

Injection, solution

구성:

Excipient Ingredients: sodium chloride; water for injections

관리 경로:

Intravenous Infusion

패키지 단위:

5 vials per pack

수업:

Medicine Listed (Export Only)

처방전 유형:

(S1) This Schedule is intentionally blank

치료 징후:

1. Relief of subjective and objective symptoms in the following diseases: Acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. Treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: Breast cancer (pre- and post-operative chemotherapy in operable cases)

제품 요약:

Visual Identification: Epirubicin Hydrochloride Injection is a clear red solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Licence status A

승인 날짜:

2013-05-08